Picture of Lipocine logo

LPCN — Lipocine News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Lipocine Inc expected to post a loss of 68 cents a share - Earnings Preview

* Lipocine Inc  LPCN.OQ   LPCN.O  is expected to show a fall
in
quarterly revenue when it reports  results on May 9 (estimated)
for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Lipocine Inc is for a
loss
of 68 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lipocine
Inc is
$33.00​, above​ its last closing price of $4.92. ​​​

This summary was machine generated May 7 at 18:32 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Lipocine

See all news